Female Pattern Hair Loss: A Review Article

    Ingrid Herskovitz, Antonella Tosti
    Image of study
    TLDR Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.
    This document is a review article on female pattern hair loss (FPHL), which is a common condition that affects millions of women. FPHL is not associated with elevated androgens, but less commonly, females with FPHL may have other skin or general signs of hyperandrogenism. The most common endocrinological abnormality associated with FPHL is polycystic ovarian syndrome (PCOS). The only approved treatment for FPHL is 2% topical Minoxidil, which should be applied at the dosage of 1ml twice a day for a minimum period of 12 months. This review discusses off-label alternative modalities of treatment including 5-alfa reductase inhibitors, antiandrogens, estrogens, prostaglandin analogs, lasers, light treatments, and hair transplantation.
    Discuss this study in the Community →

    Cited in this study

    55 / 55 results


    5 / 5 results